Allogene Therapeutics, Inc. — All Filings
537 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
144
144/A
3
4
4/A
424B4
424B5
5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DRS
EFFECT
POS EX
POS462B
POSASR
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-C
SC TO-I
SC TO-I/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | FORM 4 | 0001737287-26-000015 | Mar 18, 2026 | Mar 16, 2026 |
| 4 | FORM 4 | 0001737287-26-000013 | Mar 18, 2026 | Mar 16, 2026 |
| 144 | — | 0002057918-26-000004 | Mar 16, 2026 | — |
| 144 | — | 0001611024-26-000003 | Mar 16, 2026 | — |
| S-8 | S-8 | 0001628280-26-017307 | Mar 12, 2026 | — |
| 10-K | 10-K | 0001628280-26-017242 | Mar 12, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001628280-26-017230 | Mar 12, 2026 | — |
| 4 | FORM 4 | 0002057918-26-000003 | Mar 4, 2026 | Mar 2, 2026 |
| 144 | — | 0002057918-26-000001 | Mar 2, 2026 | — |
| SCHEDULE 13G/A | — | 0001296549-26-000004 | Feb 17, 2026 | — |
| SCHEDULE 13G | — | 0001611024-26-000002 | Feb 13, 2026 | — |
| 4 | FORM 4 | 0001737287-26-000011 | Feb 4, 2026 | Feb 2, 2026 |
| 4 | FORM 4 | 0001737287-26-000009 | Feb 4, 2026 | Feb 2, 2026 |
| 4 | FORM 4 | 0001737287-26-000007 | Feb 4, 2026 | Feb 2, 2026 |
| 4 | FORM 4 | 0001362155-26-000002 | Feb 4, 2026 | Feb 2, 2026 |
| 4 | FORM 4 | 0001737287-26-000005 | Feb 4, 2026 | Feb 2, 2026 |
| 4 | FORM 4 | 0001737287-26-000002 | Feb 4, 2026 | Feb 2, 2026 |
| 4 | FORM 4 | 0001296549-26-000002 | Feb 4, 2026 | Feb 2, 2026 |
| 144 | — | 0001950047-26-000851 | Feb 2, 2026 | — |
| 144 | — | 0001950047-26-000850 | Feb 2, 2026 | — |
| 144 | — | 0001950047-26-000849 | Feb 2, 2026 | — |
| 144 | — | 0001950047-26-000848 | Feb 2, 2026 | — |
| 144 | — | 0001950047-26-000843 | Feb 2, 2026 | — |
| 144 | — | 0001950047-26-000842 | Feb 2, 2026 | — |
| 4 | FORM 4 | 0001851044-26-000003 | Jan 23, 2026 | Jan 21, 2026 |
| 144 | — | 0001851044-26-000001 | Jan 21, 2026 | — |
| 4 | FORM 4 | 0001221355-25-000005 | Dec 22, 2025 | Dec 18, 2025 |
| 4 | FORM 4 | 0001737287-25-000094 | Nov 19, 2025 | Nov 17, 2025 |
| 144 | — | 0002057918-25-000002 | Nov 17, 2025 | — |
| SCHEDULE 13G/A | — | 0001296549-25-000005 | Nov 13, 2025 | — |
| SCHEDULE 13G/A | — | 0001422849-25-000094 | Nov 13, 2025 | — |
| SCHEDULE 13G/A | — | 0001611024-25-000004 | Nov 12, 2025 | — |
| 10-Q | 10-Q | 0001628280-25-050230 | Nov 6, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001628280-25-050227 | Nov 6, 2025 | — |
| 4 | FORM 4 | 0001737287-25-000091 | Oct 23, 2025 | Oct 21, 2025 |
| 144 | — | 0001491874-25-000005 | Oct 21, 2025 | — |
| 8-K | 8-K | 0001628280-25-044828 | Oct 14, 2025 | Sep 26, 2025 |
| 10-Q | 10-Q | 0001737287-25-000088 | Aug 13, 2025 | Jun 30, 2025 |
| 8-K | 8-K | 0001737287-25-000087 | Aug 13, 2025 | — |
| SCHEDULE 13G/A | — | 0001415889-25-021501 | Aug 12, 2025 | — |
| SCHEDULE 13G/A | — | 0001415889-25-021370 | Aug 8, 2025 | — |
| 8-K | 8-K | 0001193125-25-171091 | Aug 1, 2025 | — |
| SCHEDULE 13G | — | 0001104659-25-068409 | Jul 16, 2025 | — |
| 4 | FORM 4 | 0001737287-25-000077 | Jun 23, 2025 | Jun 18, 2025 |
| 4 | FORM 4 | 0001737287-25-000076 | Jun 23, 2025 | Jun 18, 2025 |
| 4 | FORM 4 | 0001737287-25-000075 | Jun 23, 2025 | Jun 18, 2025 |
| 4 | FORM 4 | 0001737287-25-000074 | Jun 23, 2025 | Jun 18, 2025 |
| 4 | FORM 4 | 0001737287-25-000073 | Jun 23, 2025 | Jun 18, 2025 |
| 4 | FORM 4 | 0001737287-25-000072 | Jun 23, 2025 | Jun 18, 2025 |
| 4 | FORM 4 | 0001737287-25-000071 | Jun 23, 2025 | Jun 18, 2025 |